Founded in 2020, Theranautilus is a biotechnology startup that develops nanorobot technology for dental care applications. Initially focusing on creating microscopic robots designed to improve dental ...
Funding stage:
Seed
Last funding:
18/11/2024
Total funding:
$1.20 Mn+
Revenue:
Investors
Employee count:
8
Last 90d
8
Last 90d
Web traffic:
1.13K
1.13K
Last 30d
Last 30d
Theranautilus: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders10
Latest Filing Date14 Nov 2024- Funding Events8
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Theranautilus
As of 15 November 2024, Theranautilus's equity is held by 9 shareholders, with the top three being Ambarish Ghosh, Debayan Dasgupta, and Shanmukh srinivas Shanmukh Peddi.
Ambarish Ghosh holds the largest stake in Theranautilus at 20.9% as of 15 November 2024.
As of 15 November 2024, founders collectively hold 62.7% equity in Theranautilus.
As of 15 November 2024, investors collectively hold 27.3% equity in Theranautilus.
Theranautilus's ESOP pool stands at 10.0% of total equity as of 15 November 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links